Literature DB >> 35366119

Performance and Interpretation of Hydrogen and Methane Breath Testing Impact of North American Consensus Guidelines.

Charlotte K Pitcher1, Adam D Farmer2,3,4,5, Jordan J Haworth1, Sam Treadway2, Anthony R Hobson6,7.   

Abstract

BACKGROUND: Hydrogen and methane breath tests (HMBT) are widely used clinical investigations but lack standardization. To address this, the North American Consensus (NAC) group published evidence-based recommendations for HMBT. AIMS: To evaluate results obtained using NAC recommendations for HMBT, compared to retrospective data that utilized guidelines previously recommended.
METHODS: HMBT data from 725 patients referred for small intestinal bacterial overgrowth (SIBO) and/or carbohydrate malabsorption (CM) testing were analyzed. Data were compared regarding dose of substrate for SIBO testing (16 vs. 10 g lactulose, and 50 vs. 75 g glucose) and the effect of post-ingestion sampling period for malabsorption testing. The effect of different recommended cut-off values for SIBO were examined.
RESULTS: Substrate dose did not affect methane production. 10 g lactulose significantly reduced positive SIBO results compared to 16 g lactulose (42 vs. 53%, p = 0.04). 75 g glucose significantly increased positive results compared to 50 g glucose (36 vs. 22%, p = 0.04). Provoked symptoms were significantly more prevalent in patients testing positive by both North American Consensus and Ledochowski cut-off values. 34.5% of patients tested positive for CM at 180-min compared to 28% at 120-min (not significant, p = 0.19). CONCLUSIONS AND INFERENCES: 10 g lactulose substrate produces fewer positive SIBO results than 16 g lactulose, while 75 g glucose dose produces more positive SIBO results than 50 g. Performing CM breath tests for 180 min increases number of positive results when compared to 120 min. SIBO cut-off timings require further investigation, but our findings broadly support the NAC recommendations for SIBO and CM testing.
© 2022. The Author(s).

Entities:  

Keywords:  Breath tests; Fermentation; Lactulose; Microbiome; Small intestine

Year:  2022        PMID: 35366119     DOI: 10.1007/s10620-022-07487-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  2 in total

Review 1.  Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach.

Authors:  Peter R Gibson; Susan J Shepherd
Journal:  J Gastroenterol Hepatol       Date:  2010-02       Impact factor: 4.029

2.  Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.

Authors:  Jan Tack; Vincenzo Stanghellini; Fermín Mearin; Yan Yiannakou; Peter Layer; Benoit Coffin; Magnus Simren; Jonathan Mackinnon; Gwen Wiseman; Anne Marciniak
Journal:  BMC Gastroenterol       Date:  2019-05-07       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.